menu search

FUSN / Fusion Pharmaceuticals to Present at the Guggenheim Securities Radiopharmaceuticals Day

Fusion Pharmaceuticals to Present at the Guggenheim Securities Radiopharmaceuticals Day
HAMILTON, ON and BOSTON, May 11, 2022 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the Company will participate in a fireside chat at the Guggenheim Securities Radiopharmaceuticals Day in New York, New York on Tuesday, May 17, 2022 at 3:00 p.m. ET. Presenting on behalf of Fusion will be Chief Executive Officer John Valliant, Ph.D. Read More
Posted: May 11 2022, 16:45
Author Name: PRNewsWire
Views: 102156

FUSN News  

Fusion Pharmaceuticals Inc. (FUSN) Reports Q2 Loss, Misses Revenue Estimates

By Zacks Investment Research
August 8, 2023

Fusion Pharmaceuticals Inc. (FUSN) Reports Q2 Loss, Misses Revenue Estimates

Fusion Pharmaceuticals Inc. (FUSN) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of $0.39. This comp more_horizontal

Fusion Pharmaceuticals to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day

By PRNewsWire
May 9, 2023

Fusion Pharmaceuticals to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day

HAMILTON, ON and BOSTON , May 9, 2023 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on develo more_horizontal

Fusion Pharmaceuticals to Present at the 43rd Annual Cowen Healthcare Conference

By PRNewsWire
March 2, 2023

Fusion Pharmaceuticals to Present at the 43rd Annual Cowen Healthcare Conference

HAMILTON, ON and BOSTON , March 2, 2023 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on devel more_horizontal

Fusion Pharmaceuticals to Present at the SVB Securities Global Biopharma Conference

By PRNewsWire
February 13, 2023

Fusion Pharmaceuticals to Present at the SVB Securities Global Biopharma Conference

HAMILTON, ON and BOSTON , Feb. 13, 2023 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on devel more_horizontal

Fusion Pharmaceuticals to Present at the Guggenheim Securities Radiopharmaceuticals Day

By PRNewsWire
May 11, 2022

Fusion Pharmaceuticals to Present at the Guggenheim Securities Radiopharmaceuticals Day

HAMILTON, ON and BOSTON, May 11, 2022 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on devel more_horizontal


Search within

Pages Search Results: